...
首页> 外文期刊>Radiology >Nonpalpable breast cancer: percutaneous diagnosis with 11- and 8-gauge stereotactic vacuum-assisted biopsy devices.
【24h】

Nonpalpable breast cancer: percutaneous diagnosis with 11- and 8-gauge stereotactic vacuum-assisted biopsy devices.

机译:不可触及的乳腺癌:使用11号和8号立体定向真空辅助活检设备进行经皮诊断。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To compare the accuracy of diagnosis of invasive breast cancer with 11- and 8-gauge stereotactic vacuum-assisted biopsy (SVAB) devices and to correlate lesion diameter and accuracy of breast cancer diagnosis at SVAB. MATERIALS AND METHODS: During a 22-month period, 489 SVAB procedures were performed with an 11-gauge probe and 305 with an 8-gauge probe. SVAB and surgical pathologic results of 104 breast carcinomas were reviewed and correlated with lesion size, number of specimens obtained, and type of SVAB probe used. RESULTS: Four of 38 ductal carcinoma in situ (DCIS) lesions diagnosed with 11-gauge SVAB demonstrated invasion at surgery, whereas one of 23 DCIS lesions diagnosed with 8-gauge SVAB demonstrated invasion at surgery (P =.6). A mean of 12 specimens per lesion were obtained in each group. In lesions 30 mm or larger, the underestimation rate for DCIS was 43% (three of seven) with 11-gauge SVAB and 17% (one of six) with 8-gauge SVAB (P =.6). Overall, the rate of underestimation for DCIS was significantly higher in lesions 30 mm or larger (four of 13) than in smaller lesions (one of 48, P =.006). CONCLUSION: This study demonstrated no difference in breast cancer diagnosis with the 8- and 11-gauge SVAB systems, but the accuracy of breast cancer diagnosis was greater in lesions smaller than 30 mm than in larger lesions.
机译:目的:比较11和8号立体定向真空辅助活检(SVAB)设备对浸润性乳腺癌的诊断准确性,并将病变直径和SVAB对乳腺癌的诊断准确性相关联。材料与方法:在22个月的时间内,使用11号探头进行了489个SVAB程序,使用8号探头进行了305个SVAB程序。回顾了104例乳腺癌的SVAB和手术病理结果,并将其与病变大小,获得的标本数量以及所用SVAB探针的类型相关。结果:38个导管原位癌(DCIS)病变中诊断为11号SVAB的病变中有4个在手术中表现出侵袭,而诊断为8规格SVAB的23个DCIS病变中的1个在手术中表现为侵入(P = .6)。每组平均获得12个样本。在30毫米或更大的病变中,使用11规格SVAB的DCIS被低估的比率为43%(七分之三),使用8规格SVAB的被低估率为17%(六分之一)(P = .6)。总体而言,在30 mm或更大的病变中(13个中的四个),DCIS的低估率显着高于较小的病变(48个中的一个,P = .006)。结论:这项研究表明,使用8号和11号SVAB系统的乳腺癌诊断无差异,但小于30 mm的病变的乳腺癌诊断准确性要大于较大的病变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号